BioSpace News Archive

Drug Development

Acadia’s Nuplazid Receives Regulatory Rejection for Dementia-Related Psychosis

The U.S. FDA issued a Complete Response Letter (CRL) over Acadia Pharmaceuticals’ supplemental New Drug Application (sNDA) for Nuplazid for hallucinations and delusions associated with dementia-related psychosis.

April 5, 2021
·
2 min read
·
Mark Terry
FDA

FDA Approves Novel Non-Stimulant Treatment for ADHD

Shares of Supernus Pharmaceuticals were climbing in premarket trading this morning after Friday’s announcement the U.S. FDA approved the company’s non-stimulant treatment for ADHD in pediatric patients 6 to 17 years of age.

April 5, 2021
·
2 min read
·
Alex Keown
Job Trends

After Emergent COVID-19 Manufacturing Mess, J&J Team Takes Charge

In order to have full control of J&J’s product, the production of the AstraZeneca vaccine, which was being conducted at the same facility, will move elsewhere.

April 5, 2021
·
4 min read
·
Mark Terry
Genetown

GenomeFrontier, Ziopharm Non-Viral Vectors Could Transform CAR-T Cell Therapy

Chimeric antigen receptor (CAR-T) therapy is one of the biggest cancer therapy breakthroughs of our time, but as with any precise science, there is still some fine-tuning to be done to overcome safety risks, limited payload capacity, and the prohibitive cost of manufacturing.

April 5, 2021
·
5 min read
·
Heather McKenzie
Business

Life Sciences Incubator Gets Major Renovation to Provide More Space for Startups

The San Jose BioCube life sciences incubator project has undergone a significant renovation that includes a major expansion of its headquarter facilities and also provides housing for new life sciences startups.

April 5, 2021
·
2 min read
·
Alex Keown
Business

Iveric Bio’s Co-Founder Leaves to Return to Venture Capitalist Role

He’ll make a return to his former role at SV Health Investors as a Venture Partner.

April 5, 2021
·
1 min read
·
Kate Goodwin
Heightened Hope For A Cure For HIV, With Research Reaching Inflection Point

Recent advances are giving researchers hope that a functional cure for HIV or possibly even complete eradication of the virus is possible.

April 5, 2021
·
5 min read
·
Gail Dutton
Deals

Rain Plans $100 Million IPO, Phase III Trial for Lead Precision Cancer Therapy

The news comes months after the company closed a $63 million Series B and inlicensed RAIN-32 from Daiichi Sankyo.

April 5, 2021
·
2 min read
·
Mark Zipkin
Business

J&J Bets Up to $780 Million on Cidara’s Universal Influenza Treatment

Cidara Therapeutics inked a deal worth up to $780 million with Johnson & Johnson to develop and commercialize Cidara’s candidate CD388 for the prevention and treatment of seasonal and pandemic influenza.

April 5, 2021
·
3 min read
·
Alex Keown
Enteric Softgel Capsules Market: Health supplements segment dominates the market

Softgel comprises a gelatin-based shell encompassing a semi-solid or liquid medication or concentrate filled inside it. Softgel capsules offer several advantages to customers, for example, easy usability, improved adequacy, and bioavailability.

April 5, 2021
·
4 min read